Bank of New York Mellon’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-127,474
| Closed | -$17.9M | – | 4287 |
|
|
2018
Q4 | $17.9M | Sell |
127,474
-5,674
| -4% | -$795K | 0.01% | 1548 |
|
|
2018
Q3 | $22.7M | Sell |
133,148
-2,414
| -2% | -$412K | 0.01% | 1548 |
|
|
2018
Q2 | $23.5M | Buy |
135,562
+13,033
| +11% | +$2.26M | 0.01% | 1504 |
|
|
2018
Q1 | $14.1M | Buy |
122,529
+17,298
| +16% | +$2M | ﹤0.01% | 1798 |
|
|
2017
Q4 | $8.86M | Sell |
105,231
-16,327
| -13% | -$1.37M | ﹤0.01% | 2051 |
|
|
2017
Q3 | $11.2M | Buy |
121,558
+4,018
| +3% | +$370K | ﹤0.01% | 1934 |
|
|
2017
Q2 | $9.43M | Buy |
117,540
+15,098
| +15% | +$1.21M | ﹤0.01% | 2003 |
|
|
2017
Q1 | $4.31M | Buy |
102,442
+30,210
| +42% | +$1.27M | ﹤0.01% | 2402 |
|
|
2016
Q4 | $2.32M | Buy |
72,232
+6,465
| +10% | +$208K | ﹤0.01% | 2763 |
|
|
2016
Q3 | $1.72M | Sell |
65,767
-31,370
| -32% | -$821K | ﹤0.01% | 2849 |
|
|
2016
Q2 | $2.25M | Buy |
97,137
+26,600
| +38% | +$617K | ﹤0.01% | 2644 |
|
|
2016
Q1 | $1.93M | Buy |
70,537
+30,646
| +77% | +$838K | ﹤0.01% | 2680 |
|
|
2015
Q4 | $1.14M | Buy |
39,891
+5,974
| +18% | +$170K | ﹤0.01% | 3080 |
|
|
2015
Q3 | $593K | Sell |
33,917
-9,618
| -22% | -$168K | ﹤0.01% | 3475 |
|
|
2015
Q2 | $786K | Buy |
43,535
+9,970
| +30% | +$180K | ﹤0.01% | 3467 |
|
|
2015
Q1 | $417K | Buy |
33,565
+13,301
| +66% | +$165K | ﹤0.01% | 3679 |
|
|
2014
Q4 | $238K | Buy |
20,264
+1,091
| +6% | +$12.8K | ﹤0.01% | 3843 |
|
|
2014
Q3 | $252K | Buy |
+19,173
| New | +$252K | ﹤0.01% | 3827 |
|